Transforming growth factor-1 promotes the transcriptional activation of plasminogen activator inhibitor type 1 in carcinoma-associated fibroblasts

By              

Molecular Medicine Reports, Vol. 6, Iss. 5, 2012-01 ,pp. : 1001-1005

Spandidos Publications

Access to resources Recommend Favorite

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

By Moriyama Takuzou   Kataoka Hiroaki   Hamasuna Ryouichi   Yoshida Etsuo   Sameshima Tetsuro   Iseda Tsutomu   Yokogami Kiyotaka   Nakano Shinichi   Koono Masashi   Wakisaka Shinichiro  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 873-879

Springer Publishing Company

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

By Tecimer C.   Doering D.L.   Goldsmith L.J.   Meyer J.S.   Abdulhay G.   Wittliff J.L.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 48-55

Elsevier

Access to resources Recommend Favorite

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

By Wang Bin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite